Overview
ECMO has improved the outcome of heart or respiratory failure and carcinogenic shock and are increasingly used. However bleeding complications occurring in up to 50% of patients are poorly understood and worsen the overall results. The aim is to investigate the occurence of bleeding and its frequency according to the type of ECMO either veno-arterial or veno-venous. The investigators also want to assess the relation of bleeding with von Willebrand Factor defects.
Eligibility
Inclusion Criteria:
- informed consent of patient or person in charge
- patient supplied by an ECMO for cardiac or respiratory failure and referred to Lille University Hospital
- patient affiliated to "french social security"
Exclusion Criteria:
- pregnant woman
- no consent
- no affiliation to
- patient affiliated to '
- preexisting bleeding disorders